AmacaThera Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 11
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $8.89M
Latest Deal Amount
  • Investors
  • 16

AmacaThera General Information

Description

Developer of a hydrogel technology designed to enable sustained drug release. The company's technology offer a fast gelling material that liquefies under force and it is a reversible and fast gelling physical blend of hyaluronan (HA) and methylcellulose (MC), enabling doctors to help reduce patients' post-operative pain.

Contact Information

Website
www.amacathera.ca
Formerly Known As
Hammock Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • 661 University Avenue
  • Suite 1300
  • Toronto, Ontario M5G 0B7
  • Canada
+1 (647) 000-0000

AmacaThera Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

AmacaThera Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Early Stage VC (Series A) 02-Nov-2020 $8.89M 000.00 Completed Generating Revenue
6. Seed Round 03-Oct-2019 00.000 00.000 Completed Generating Revenue
5. Accelerator/Incubator 01-Mar-2019 0000 Completed Generating Revenue
4. Accelerator/Incubator 0000 0000 Completed Startup
3. Accelerator/Incubator 0000 Completed Startup
2. Accelerator/Incubator 09-May-2016 $50K $50K Completed Startup
1. Accelerator/Incubator Completed Startup
To view AmacaThera’s complete valuation and funding history, request access »

AmacaThera Executive Team (2)

Name Title Board Seat Contact Info
Michael Cooke Ph.D Co-Founder, Board Member & Chief Executive Officer
Molly Shoichet Ph.D Co-Founder, Chief Scientific Officer & Board Member
To view AmacaThera’s complete executive team members history, request access »

AmacaThera Board Members (4)

Name Representing Role Since
Andrew Bishop Self Board Member 000 0000
Michael Cooke Ph.D AmacaThera Co-Founder, Board Member & Chief Executive Officer 000 0000
Molly Shoichet Ph.D AmacaThera Co-Founder, Chief Scientific Officer & Board Member 000 0000
Peter Velden AmacaThera Board Member 000 0000
To view AmacaThera’s complete board members history, request access »

AmacaThera Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AmacaThera Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BDC Capital Venture Capital Minority 000 0000 000000 0
China Resources Capital Management Corporate Venture Capital Minority 000 0000 000000 0
Inveready Technology Investment Group Venture Capital Minority 000 0000 000000 0
MaRS Investment Accelerator Fund Venture Capital Minority 000 0000 000000 0
StandUp Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 16 investors. Get the full list »

Ready to get started?

Request a free trial